Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer (MDX010-21)
This study is ongoing, but not recruiting participants.
Sponsor:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT00323882
First received: May 8, 2006
Last updated: December 29, 2011
Last verified: December 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2015 |
| Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | January 29, 2011 |